ARTICLE | Clinical News
NexGenix preclinical data
March 3, 2008 8:00 AM UTC
Data from breast cancer tumor xenografts showed that a single dose of NXD30001 inhibited cell proliferation and depleted multiple heat shock protein 90 (Hsp90) client proteins (eg, HER2, c-raf), whi...